echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Immunity: Key insights into the complex biology of tissue-specific T cells

    Immunity: Key insights into the complex biology of tissue-specific T cells

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
          

       

    T cells play an important role
    in immunity, autoimmunity, and cancer.


    Recent pressure to maximize vaccine efficacy has stirred up many new discoveries in the field of immunology, revealing many paradigms of untapped therapeutic potential
    .
    Tissue-resident memory T cells (TRM cells), an immune cell that provides long-lasting protection against pathogens attacking specific organs and tissues
    .

    In a new study published December 28, 2022, scientists at the UC San Diego School of Medicine have revealed cell biology in the TRM gut, which could inspire a new generation of precise treatments
    for infections, cancer, and autoimmune diseases.

    After experiencing an infection, the immune system leaves memory T cells that maintain a long-term molecular memory of the pathogen and are ready to sound the alarm if the
    pathogen reappears.
    While some memory T cells are designed to circulate through the bloodstream and provide whole-body protection, others reside in specific organs specifically designed to fight pathogens
    that target that part of the body.
    TheseTRM cells can provide lifelong immunity to the target tissue, but can also promote autoimmune diseases if coped
    .

    "TRM cells are the first responders, right on the front lines of infection," said
    senior author John T.
    Chang, M.
    D.
    , a professor at the University of California, San Diego School of Medicine.
    "Most of our vaccines are designed to provide systemic immunity, but if we focus on enhancing tissue-specific cells that encounter pathogens first, we may get better protection
    .
    "

    For example, the best way to fight respiratory viruses may be to strengthen the cells in the nose and lungs of the T-virus RM, as well as a pathogenic gut microbe, preferably by strengthening the cells
    in the T RM gut.
    Therefore, we aim to develop treatments that promote the formation and maintenance of TRM cells or, in the case of autoimmune diseases, remove immune cells
    by disrupting these same pathways.

    The problem is that scientists still have a lot to learn about what helpsTrm cells form and survive, and these rules can be quite different
    in each tissue type.

    To explore this, the researchers conducted a series of experiments to characterize cells in TRM mice from four different regions of the gut: two organs (small intestine and colon), each with two different tissue layers (inner epithelial and proprium).

    Experiments have shown that cells of TRM per tissue type exhibit different cytokine and granzyme expression patterns, as well as substantial transcriptional, epigenetic, and functional heterogeneity
    .
    In other words, in each part of the gut, the same type of immune cells appear to differ
    greatly in molecular composition, function, and the chemical signals they rely on.

    Further reinforcing this, each cell population also exhibits a different dependence on demesoembryonic proteins (Eomes), a transcription factor known to influence the development of
    TRM cells.
    Eomes are often thought to inhibit TRM These cells are based on data previously collected from the skin, liver and kidneys, but new experiments show that the opposite is true in the small intestine
    .
    There, Eomes was shown in TRM cells
    .
    However, this is not the case in the colon, which highlights the high degree of environmental specificity
    even in the intestine.

    Future studies will continue to define the rules for the formation and maintenance of TRM cells in other tissues and explore what drives their specificity
    .
    For example, the authors suggest that differences in the microbiota of the small intestine and colon may contribute to their unique demand for TRM cells, so manipulating the microbiome may be another way
    to modulate gut immune cells.

    "In the future, we hope to consider vaccines and other treatments tailored to the specific needs of each organ," Chang said
    .
    "By understanding what each tissue type needs to support the formation and maintenance of TRM cells, we can provide the most effective immune defense against disease
    .
    "


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.